165 related articles for article (PubMed ID: 1281807)
1. Efficacy and safety of sotalol in patients with complex ventricular arrhythmias.
Hohnloser SH; Zabel M; van de Loo A; Klingenheben T; Just H
Int J Cardiol; 1992 Dec; 37(3):283-91. PubMed ID: 1281807
[TBL] [Abstract][Full Text] [Related]
2. Short- and long-term antiarrhythmic and hemodynamic effects of d,l-sotalol in patients with symptomatic ventricular arrhythmias.
Hohnloser SH; Zabel M; Krause T; Just H
Am Heart J; 1992 May; 123(5):1220-4. PubMed ID: 1575137
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of d, I sotalol for suppression of chronic ventricular arrhythmias.
Anastasiou-Nana MI; Gilbert EM; Miller RH; Singh S; Freedman RA; Keefe DL; Saksena S; MacNeil DJ; Anderson JL
Am J Cardiol; 1991 Mar; 67(6):511-6. PubMed ID: 1705386
[TBL] [Abstract][Full Text] [Related]
4. Evolving role of sotalol in the management of ventricular tachyarrhythmias.
O'Callaghan PA; McGovern BA
Am J Cardiol; 1996 Aug; 78(4A):54-60. PubMed ID: 8780329
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of oral sotalol for sustained ventricular tachyarrhythmias refractory to other antiarrhythmic agents.
Kehoe RF; MacNeil DJ; Zheutlin TA; Ezri MD; Nazari J; Spangenberg RB; Dunnington C; Lueken M
Am J Cardiol; 1993 Aug; 72(4):56A-66A. PubMed ID: 8346728
[TBL] [Abstract][Full Text] [Related]
6. Multicenter trial of sotalol for suppression of frequent, complex ventricular arrhythmias: a double-blind, randomized, placebo-controlled evaluation of two doses.
Anderson JL; Askins JC; Gilbert EM; Miller RH; Keefe DL; Somberg JC; Freedman RA; Haft LR; Mason JW; Lessem JN
J Am Coll Cardiol; 1986 Oct; 8(4):752-62. PubMed ID: 2428852
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and proarrhythmia with the use of d,l-sotalol for sustained ventricular tachyarrhythmias.
Kühlkamp V; Mermi J; Mewis C; Seipel L
J Cardiovasc Pharmacol; 1997 Mar; 29(3):373-81. PubMed ID: 9125676
[TBL] [Abstract][Full Text] [Related]
8. [Effect of sotalol on heart rate variability in patients with symptomatic, complex ventricular arrhythmias].
Klingenheben T; Hohnloser SH
Z Kardiol; 1994 Apr; 83(4):293-8. PubMed ID: 8023542
[TBL] [Abstract][Full Text] [Related]
9. [Results of oral sotalol therapy in children with supraventricular and ventricular arrhythmias].
Paul T; Lehmann C; Pfammatter JP; Kallfelz HC
Z Kardiol; 1994 Dec; 83(12):891-7. PubMed ID: 7531374
[TBL] [Abstract][Full Text] [Related]
10. Long-term antiarrhythmic efficacy and safety of d-sotalol in patients with ventricular tachycardia and a low ejection fraction.
Koch KT; Düren DR; van Zwieten PA
Cardiovasc Drugs Ther; 1995 Jun; 9(3):437-43. PubMed ID: 8527354
[TBL] [Abstract][Full Text] [Related]
11. Relation of diurnal variation of ventricular repolarization to ventricular ectopic activity and modification by sotalol.
Hohnloser SH; Zabel M; Just H; Raeder EA
Am J Cardiol; 1993 Feb; 71(5):475-8. PubMed ID: 7679244
[No Abstract] [Full Text] [Related]
12. Clinical safety profile of sotalol in the treatment of arrhythmias.
MacNeil DJ; Davies RO; Deitchman D
Am J Cardiol; 1993 Aug; 72(4):44A-50A. PubMed ID: 8346726
[TBL] [Abstract][Full Text] [Related]
13. Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.
Fitton A; Sorkin EM
Drugs; 1993 Oct; 46(4):678-719. PubMed ID: 7506652
[TBL] [Abstract][Full Text] [Related]
14. Is hospital admission for initiation of antiarrhythmic therapy with sotalol for atrial arrhythmias required? Yield of in-hospital monitoring and prediction of risk for significant arrhythmia complications.
Chung MK; Schweikert RA; Wilkoff BL; Niebauer MJ; Pinski SL; Trohman RG; Kidwell GA; Jaeger FJ; Morant VA; Miller DP; Tchou PJ
J Am Coll Cardiol; 1998 Jul; 32(1):169-76. PubMed ID: 9669266
[TBL] [Abstract][Full Text] [Related]
15. Practical considerations in the use of sotalol for ventricular tachycardia and ventricular fibrillation.
Campbell RW; Furniss SS
Am J Cardiol; 1993 Aug; 72(4):80A-85A. PubMed ID: 8346732
[TBL] [Abstract][Full Text] [Related]
16. Sotalol: An important new antiarrhythmic.
Anderson JL; Prystowsky EN
Am Heart J; 1999 Mar; 137(3):388-409. PubMed ID: 10047618
[TBL] [Abstract][Full Text] [Related]
17. Response to sotalol predicts the response to amiodarone during serial drug testing in patients with sustained ventricular tachycardia and coronary artery disease.
Martínez-Rubio A; Shenasa M; Chen X; Wichter T; Breithardt G; Borggrefe M
Am J Cardiol; 1994 Feb; 73(5):357-60. PubMed ID: 7509121
[TBL] [Abstract][Full Text] [Related]
18. Adverse event rate during inpatient sotalol initiation for the management of supraventricular and ventricular tachycardia in the pediatric and young adult population.
Chandler SF; Chu E; Whitehill RD; Bevilacqua LM; Bezzerides VJ; DeWitt ES; Alexander ME; Abrams DJ; Triedman JK; Walsh EP; Mah DY
Heart Rhythm; 2020 Jun; 17(6):984-990. PubMed ID: 32014568
[TBL] [Abstract][Full Text] [Related]
19. Clinical safety profile of sotalol in patients with arrhythmias.
Soyka LF; Wirtz C; Spangenberg RB
Am J Cardiol; 1990 Jan; 65(2):74A-81A; discussion 82A-83A. PubMed ID: 2403737
[TBL] [Abstract][Full Text] [Related]
20. Clinical experience with sotalol in the treatment of cardiac arrhythmias.
Kirschenbaum HL; Rosenberg JM
Clin Ther; 1994; 16(3):346-64. PubMed ID: 7923303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
